C
C. Bedrosian
Researcher at Royal Devon and Exeter Hospital
Publications - 3
Citations - 1223
C. Bedrosian is an academic researcher from Royal Devon and Exeter Hospital. The author has contributed to research in topics: Eculizumab & Atypical hemolytic uremic syndrome. The author has an hindex of 2, co-authored 3 publications receiving 1007 citations.
Papers
More filters
Journal ArticleDOI
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Ch. Legendre,Christoph Licht,Petra Muus,Laurence Greenbaum,Sunil Babu,C. Bedrosian,C. Bingham,David J. Cohen,Y. Delmas,Kenneth W. Douglas,Frank Eitner,Thorsten Feldkamp,Denis Fouque,Richard R. Furman,Osama Gaber,Maria Herthelius,Maryvonne Hourmant,Diana Karpman,Yvon Lebranchu,Christophe Mariat,Jan Menne,Bruno Moulin,Jens Nürnberger,Masayo Ogawa,Giuseppe Remuzzi,T. Richard,Rebecca Sberro-Soussan,B. Severino,Neil S. Sheerin,Antonella Trivelli,L.B. Zimmerhackl,Timothy H.J. Goodship,Chantal Loirat +32 more
TL;DR: Eculizumab inhibited complement-mediated thrombotic microangiopathy and was associated with significant time-dependent improvement in renal function in patients with atypical hemolytic-uremic syndrome and was also associated with improvement in health-related quality of life.
Journal ArticleDOI
Interim analysis of phase II efficacy and safety data for eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) receiving chronic plasma exchange/infusion
Timothy H.J. Goodship,Petra Muus,Christophe Legendre,Kenneth W. Douglas,Maryvonne Hourmant,Y. Delmas,Maria Herthelius,Antonella Trivelli,Chantal Loirat,C. Bedrosian,Christoph Licht +10 more